Aged care reforms could see clients disadvantaged
Financial advisers will need to untangle the complexities of the new aged care reforms so that their clients do not miss out on income, a fund management firm believes.
The reforms, due to hit July next year, come with a raft of new requirements and terminology changes, which if not managed properly, could see clients disadvantaged, Anna Lawton, senior manager, aged care services at Equity Trustees Limited (EQT), said.
"The reforms shift the system from an income tested fee to a broader means tested fee," Lawton said.
One of the key changes is the replacement of accommodation bonds with refundable accommodation deposits (RADS), which unlike their predecessor will be capped.
"The biggest change from a resident's cost point of view is that RADs will count as an asset while only the first $153,905 of a Principal Residence will be taken into account and included as an asset," Lawton said.
The aged care manager said that as a result, residents should be encouraged to pay off their RADS upfront and in full.
"There are a number of strategies that need to be considered, depending on the level of assets and income a person has. Professional advice will be required, to ensure the approach taken best maximises cash flow and capital preservation," Lawton said.
Recommended for you
Having received bids from Bell Financial Group and AxiCorp, trading platform Selfwealth has confirmed it has entered into a scheme implementation deed after both parties were invited to make a higher bid.
Clime Investment Management has faced shareholder backlash around “unsatisfactory” financial results and is enacting cost reductions to return the business to profitability by Q1 2025.
Ausbil has expanded its distribution team with the hire of a manager for investment research and consulting, following the exit of its head of wholesale distribution in July.
Amid a growing appetite for alternatives, investment executives have shared questions advisers should consider when selecting a private markets product compared to their listed counterparts.
